Gumen, Jerwin D.

HRN: 04-07-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
CEFUROXIME 750MG (VIAL)
06/02/2026
06/09/2026
IV
750mg
Q8
TBi
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines